GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Titan Biotech Ltd

Titan Biotech Board Meeting to Approve Q2 & Half-Year FY26 Results on Nov 05, 2026

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 31 Oct 2026, 06:36 PM IST  ·  BSE ID: 75fc90c1-41a1-4c59-ab10-12093af7a3f7
View Original BSE Filing (PDF)
💡
In Simple Terms
Titan Biotech's board will meet on November 5, 2026, to review its financial performance for the second quarter and half year.
🤖 AI Summary
  • Titan Biotech Board Meeting scheduled for Thursday, November 05, 2026.
  • Purpose is to consider and approve unaudited standalone and consolidated financial results for Q2 & half year ended September 30, 2026.
  • Trading Window for designated persons closed from October 1, 2026.
  • Trading Window will remain closed until 48 hours after the Board Meeting outcome on November 05, 2026.
  • Meeting also includes consideration of any other business with Chairman's permission.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders may review the financial results once declared.
👤
Who Is Affected
All shareholders will be affected by the financial results once they are considered and approved by the Board, as these results provide an update on the company's performance.
🔍
Management Signal
The scheduling of the Board Meeting and closure of the trading window signals adherence to regulatory compliance and the standard process for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board Meeting outcome on November 05, 2026.
Unaudited Q2 & Half-Year FY26 financial results declaration.
Trading Window reopening date post results declaration.
LOW RISK The filing is a routine announcement of a board meeting for financial results, carrying no inherent immediate risk.
💡 Investor Takeaway
Titan Biotech Limited has scheduled a Board Meeting for November 05, 2026, to approve unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026. The Trading Window for designated persons is closed from October 1, 2026, until 48 hours post-meeting.
❓ Frequently Asked Questions
When is Titan Biotech's next Board Meeting scheduled?
Titan Biotech Limited's Board Meeting is scheduled for Thursday, November 05, 2026, at 903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi-110034, India.
What is the primary agenda for the Titan Biotech Board Meeting on November 05, 2026?
The primary agenda for the Board Meeting is to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026.
When did the Trading Window close for Titan Biotech Limited?
The Trading Window for dealing in Titan Biotech Limited securities by designated persons has been closed from Thursday, October 1, 2026.
When will the Trading Window reopen for Titan Biotech Limited?
The Trading Window will remain closed until 48 hours after the declaration of the outcome of the Board Meeting scheduled for Thursday, November 05, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.